Previous Close | 0.9000 |
Open | 0.9000 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 0.9000 - 0.9000 |
52 Week Range | 0.9000 - 1.3000 |
Volume | |
Avg. Volume | 45 |
Market Cap | 24.606M |
Beta (5Y Monthly) | 0.30 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for MVRBF
Medivir AB (Nasdaq Stockholm: MVIR) today announced that IGM Biosciences, Inc. has initiated its clinical study in solid cancers with birinapant (a k a IGM-9427) in combination with IGM's DR5 agonist antibody IGM-8444 (NCT04553692).
Medivir AB (Nasdaq Stockholm: MVIR) today announces that the company will present at the ProHearings shared Capital Markets Day, October 14, 2021.